These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15238787)

  • 1. Nail, hair and skin hyperpigmentation associated with indinavir therapy.
    Terheggen F; Frissen J; Weigel H; Schouten I; Brinkman K
    AIDS; 2004 Jul; 18(11):1612. PubMed ID: 15238787
    [No Abstract]   [Full Text] [Related]  

  • 2. Indinavir use: associated reversible hair loss and mood disturbance.
    Harry TC; Matthews M; Salvary I
    Int J STD AIDS; 2000 Jul; 11(7):474-6. PubMed ID: 10919491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired reactive perforating collagenosis induced by indinavir in 2 patients with HIV disease.
    Calista D; Morri M
    Eur J Dermatol; 2008; 18(1):84-5. PubMed ID: 18086600
    [No Abstract]   [Full Text] [Related]  

  • 4. Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient.
    Laughon SK; Shinn LL; Nunley JR
    Int J Dermatol; 2000 Dec; 39(12):928-31. PubMed ID: 11168664
    [No Abstract]   [Full Text] [Related]  

  • 5. Indinavir crystalluria.
    Gagnon RF; Alli AI; Watters AK; Tsoukas CM
    Kidney Int; 2006 Dec; 70(12):2047. PubMed ID: 17136127
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible acute haemolysis associated with indinavir.
    Watson A
    AIDS; 2000 Mar; 14(4):465-6. PubMed ID: 10770553
    [No Abstract]   [Full Text] [Related]  

  • 7. Indinavir and thrombocytopenia.
    Durand JM
    AIDS; 1999 Jan; 13(1):148-9. PubMed ID: 10207566
    [No Abstract]   [Full Text] [Related]  

  • 8. Indinavir-induced thrombocytopenia.
    Camino N; Núñez M; Blanco F; González-Requena D; González-Lahoz J; Soriano V
    AIDS Patient Care STDS; 2003 Mar; 17(3):103-4. PubMed ID: 12724005
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous side effects induced by indinavir.
    Calista D; Boschini A
    Eur J Dermatol; 2000 Jun; 10(4):292-6. PubMed ID: 10846257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS case histories: indinavir crystalluria.
    Godwin TA
    AIDS Patient Care STDS; 2001 Mar; 15(3):169-71. PubMed ID: 11313030
    [No Abstract]   [Full Text] [Related]  

  • 11. [Crystalluria and nephrolithiasis during therapy with the protease inhibitor indinavir].
    Rickerts V; Kober A; Stille W
    Dtsch Med Wochenschr; 1997 Jun; 122(24):803. PubMed ID: 9229567
    [No Abstract]   [Full Text] [Related]  

  • 12. Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection.
    Colebunders R; De Schacht C; Vanwolleghem T; Callens S
    Int J Infect Dis; 2004 Sep; 8(5):315-6. PubMed ID: 15325601
    [No Abstract]   [Full Text] [Related]  

  • 13. Sudden anuria due to indinavir crystalluria.
    Anglicheau D; Duvic C; Nédélec G
    Nephron; 2000 Nov; 86(3):364-5. PubMed ID: 11096305
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapsing blepharitis in patients under highly active antiretroviral therapy including indinavir.
    Lozano F; León EM; Mira JA; Corzo JE; Gómez-Mateos JM
    AIDS; 2004 Jan; 18(2):354-6. PubMed ID: 15075566
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute respiratory failure associated with the human immunodeficiency virus (HIV) protease inhibitor indinavir in an HIV-infected patient.
    Dieleman JP; in 't Veld B; Borleffs JC; Schreij G
    Clin Infect Dis; 1998 Apr; 26(4):1012-3. PubMed ID: 9564505
    [No Abstract]   [Full Text] [Related]  

  • 16. Rheumatological complications associated with the use of indinavir and other protease inhibitors.
    Florence E; Schrooten W; Verdonck K; Dreezen C; Colebunders R
    Ann Rheum Dis; 2002 Jan; 61(1):82-4. PubMed ID: 11779768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor.
    Carr A; Brown D; Cooper DA
    AIDS; 1997 Nov; 11(13):1657-8. PubMed ID: 9365776
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe coronary artery disease in a young HIV-infected man with no cardiovascular risk factor who was treated with indinavir.
    Karmochkine M; Raguin G
    AIDS; 1998 Dec; 12(18):2499. PubMed ID: 9875590
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe hypertension and renal atrophy associated with indinavir.
    Cattelan AM; Trevenzoli M; Naso A; Meneghetti F; Cadrobbi P
    Clin Infect Dis; 2000 Mar; 30(3):619-21. PubMed ID: 10722466
    [No Abstract]   [Full Text] [Related]  

  • 20. Ureteral obstruction secondary to indinavir in the pediatric HIV population.
    Noble CB; Klein LT; Staiman VR; Neu N; Hensle TW; Berdon WE
    Pediatr Radiol; 1998 Aug; 28(8):627-9. PubMed ID: 9716639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.